Swing Therapeutics Achieved 97% Patient Compliance With ePRO

Swing Therapeutics leveraged Medrio ePRO in a proof-of-concept for a decentralized hybrid study. Electronic Patient-Reported Outcomes (ePRO) technology was used to assess the results of varying digital therapies and the feasibility of conducting a largely virtual clinical study in a fibromyalgia population. Due to the ePRO ease of use, SMS notifications, and a bring-your-own-device (BYOD) model, the pilot study was able to achieve 97% patient compliance. This success was paired with a significant increase in patient engagement and reduction of site burden.